Momenta Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
78.31 M |
Public Float |
46 M |
Momenta Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.12 |
Market Cap |
$1.2 B |
Shares Outstanding |
98.61 M |
Public Float |
96.65 M |
Address |
301 Binney Street Cambridge Massachusetts 02142 United States |
Employees | - |
Website | http://www.momentapharma.com |
Updated | 07/08/2019 |
Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. |